Breaking News

Altea, Hospira To Develop Transdermal Product

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Altea Therapeutics has entered into a partnership with Hospira for the development and commercialization of an undisclosed product using its PassPort Transdermal Delivery System. Under the terms of the agreement, Hospira has exclusive worldwide rights to develop and commercialize the product. Altea will fund certain Phase I studies and Hospira will fund all further product development, manufacturing, and commercialization. Altea will receive an upfront payment, which includes an equity investmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters